
MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US 25 August 2020
MC2 Therapeutics, a commercial stage pharmaceutical company focused on innovative topical therapies for... Read more